Skip to main content
Top
Published in: Breast Cancer Research 1/2002

01-02-2002 | Commentary

Complex roles for telomeres and telomerase in breast carcinogenesis

Author: Steven E Artandi

Published in: Breast Cancer Research | Issue 1/2002

Login to get access

Abstract

Telomerase – an enzyme that endows cells with unlimited proliferative potential – is differentially expressed in cancer cells and in normal cells. Although most primary human cells lack telomerase, the enzyme is upregulated in more than 90% of invasive breast cancers. As a result, much of breast cancer development occurs before telomerase is reactivated during a critical transition from a telomerase-negative to a telomerase-positive state. During this transition, the telomere shortening that accompanies cell division may either prevent or facilitate tumorigenesis by activating checkpoints and impairing chromosomal stability. In mature cancers, telomerase probably serves a crucial role in tumor progression and maintenance by stabilizing telomeres and supporting the immortal growth of breast cancer cells.
Literature
1.
go back to reference Blackburn EH: Switching and signaling at the telomere. Cell. 2001, 106: 661-673. 10.1016/S0092-8674(01)00492-5.CrossRefPubMed Blackburn EH: Switching and signaling at the telomere. Cell. 2001, 106: 661-673. 10.1016/S0092-8674(01)00492-5.CrossRefPubMed
2.
go back to reference Counter CM, Avilion AA, LeFeuvre CE, Stewart NG, Greider CW, Harley CB, Bacchetti S: Telomere shortening associated with chromosome instability is arrested in immortal cells which express telomerase activity. EMBO J. 1992, 11: 1921-1929.PubMedPubMedCentral Counter CM, Avilion AA, LeFeuvre CE, Stewart NG, Greider CW, Harley CB, Bacchetti S: Telomere shortening associated with chromosome instability is arrested in immortal cells which express telomerase activity. EMBO J. 1992, 11: 1921-1929.PubMedPubMedCentral
3.
go back to reference Stewart SA, Weinberg RA: Senescence: does it all happen at the ends?. Oncogene. 2002, 21: 627-630. 10.1038/sj.onc.1205062.CrossRefPubMed Stewart SA, Weinberg RA: Senescence: does it all happen at the ends?. Oncogene. 2002, 21: 627-630. 10.1038/sj.onc.1205062.CrossRefPubMed
4.
go back to reference Foster SA, Wong DJ, Barrett MT, Galloway DA: Inactivation of p16 in human mammary epithelial cells by CpG island methylation. Mol Cell Biol. 1998, 18: 1793-1801.CrossRefPubMedPubMedCentral Foster SA, Wong DJ, Barrett MT, Galloway DA: Inactivation of p16 in human mammary epithelial cells by CpG island methylation. Mol Cell Biol. 1998, 18: 1793-1801.CrossRefPubMedPubMedCentral
5.
go back to reference Romanov SR, Kozakiewicz BK, Holst CR, Stampfer MR, Haupt LM, Tlsty TD: Normal human mammary epithelial cells spontaneously escape senescence and acquire genomic changes. Nature. 2001, 409: 633-637. 10.1038/35054579.CrossRefPubMed Romanov SR, Kozakiewicz BK, Holst CR, Stampfer MR, Haupt LM, Tlsty TD: Normal human mammary epithelial cells spontaneously escape senescence and acquire genomic changes. Nature. 2001, 409: 633-637. 10.1038/35054579.CrossRefPubMed
6.
go back to reference Kiyono T, Foster SA, Koop JI, McDougall JK, Galloway D, Klingelhutz AJ: Both Rb/p16INK4a inactivation and telomerase activity are required to immortalize human epithelial cells. Nature. 1998, 396: 84-88. 10.1038/23962.CrossRefPubMed Kiyono T, Foster SA, Koop JI, McDougall JK, Galloway D, Klingelhutz AJ: Both Rb/p16INK4a inactivation and telomerase activity are required to immortalize human epithelial cells. Nature. 1998, 396: 84-88. 10.1038/23962.CrossRefPubMed
7.
go back to reference Ramirez RD, Morales CP, Herbert BS, Rohde JM, Passons C, Shay JW, Wright WE: Putative telomere-independent mechanisms of replicative aging reflect inadequate growth conditions. Genes Dev. 2001, 15: 398-403. 10.1101/gad.859201.CrossRefPubMedPubMedCentral Ramirez RD, Morales CP, Herbert BS, Rohde JM, Passons C, Shay JW, Wright WE: Putative telomere-independent mechanisms of replicative aging reflect inadequate growth conditions. Genes Dev. 2001, 15: 398-403. 10.1101/gad.859201.CrossRefPubMedPubMedCentral
8.
go back to reference Blasco MA, Lee HW, hande MP, Samper E, Lansdorp PM, DePinho RA, Greider CW: Telomere shortening and tumor formation by mouse cells lacking telomerase RNA. Cell. 1997, 91: 25-34. 10.1016/S0092-8674(01)80006-4.CrossRefPubMed Blasco MA, Lee HW, hande MP, Samper E, Lansdorp PM, DePinho RA, Greider CW: Telomere shortening and tumor formation by mouse cells lacking telomerase RNA. Cell. 1997, 91: 25-34. 10.1016/S0092-8674(01)80006-4.CrossRefPubMed
9.
go back to reference Lee HW, Blasco MA, Gottlieb GJ, Horner JW, Greider CW, DePinho RA: Essential role of mouse telomerase in highly proliferative organs. Nature. 1998, 392: 569-574. 10.1038/33345.CrossRefPubMed Lee HW, Blasco MA, Gottlieb GJ, Horner JW, Greider CW, DePinho RA: Essential role of mouse telomerase in highly proliferative organs. Nature. 1998, 392: 569-574. 10.1038/33345.CrossRefPubMed
10.
go back to reference Chin L, Artandi SE, Shen Q, Tam A, Lee SL, Gottlieb GJ, Greider CW, DePinho RA: p53 deficiency rescues the adverse effects of telomere loss and cooperates with telomere dysfunction to accelerate carcinogenesis. Cell. 1999, 97: 527-538. 10.1016/S0092-8674(00)80762-X.CrossRefPubMed Chin L, Artandi SE, Shen Q, Tam A, Lee SL, Gottlieb GJ, Greider CW, DePinho RA: p53 deficiency rescues the adverse effects of telomere loss and cooperates with telomere dysfunction to accelerate carcinogenesis. Cell. 1999, 97: 527-538. 10.1016/S0092-8674(00)80762-X.CrossRefPubMed
11.
go back to reference Gonzalez-Suarez E, Samper E, Flores JM, Blasco MA: Telomerase-deficient mice with short telomeres are resistant to skin tumorigenesis. Nat Genet. 2000, 26: 114-117. 10.1038/79089.CrossRefPubMed Gonzalez-Suarez E, Samper E, Flores JM, Blasco MA: Telomerase-deficient mice with short telomeres are resistant to skin tumorigenesis. Nat Genet. 2000, 26: 114-117. 10.1038/79089.CrossRefPubMed
12.
go back to reference Greenberg RA, Chin L, Femino A, Lee KH, Gottlieb GJ, Singer RH, Greider CW, DePinho RA: Short dysfunctional telomeres impair tumorigenesis in the INK4a(delta2/3) cancer-prone mouse. Cell. 1999, 97: 515-525. 10.1016/S0092-8674(00)80761-8.CrossRefPubMed Greenberg RA, Chin L, Femino A, Lee KH, Gottlieb GJ, Singer RH, Greider CW, DePinho RA: Short dysfunctional telomeres impair tumorigenesis in the INK4a(delta2/3) cancer-prone mouse. Cell. 1999, 97: 515-525. 10.1016/S0092-8674(00)80761-8.CrossRefPubMed
13.
go back to reference Rudolph KL, Millard M, Bosenberg MW, DePinho RA: Telomere dysfunction and evolution of intestinal carcinoma in mice and humans. Nat Genet. 2001, 28: 155-159. 10.1038/88871.CrossRefPubMed Rudolph KL, Millard M, Bosenberg MW, DePinho RA: Telomere dysfunction and evolution of intestinal carcinoma in mice and humans. Nat Genet. 2001, 28: 155-159. 10.1038/88871.CrossRefPubMed
14.
go back to reference Artandi SE, Chang S, Lee SL, Alson S, Gottlieb GJ, Chin L, DePinho RA: Telomere dysfunction promotes non-reciprocal translocations and epithelial cancers in mice. Nature. 2000, 406: 641-645. 10.1038/35020592.CrossRefPubMed Artandi SE, Chang S, Lee SL, Alson S, Gottlieb GJ, Chin L, DePinho RA: Telomere dysfunction promotes non-reciprocal translocations and epithelial cancers in mice. Nature. 2000, 406: 641-645. 10.1038/35020592.CrossRefPubMed
15.
go back to reference O'Hagan RC, Chang S, Maser RS, Mohan R, Artandi SE, Chin L, DePinho RA: Telomere dysfunction provokes regional amplification and deletion in cancer genomes. Cancer Cell. 2002, 2: 149-155. 10.1016/S1535-6108(02)00094-6.CrossRefPubMed O'Hagan RC, Chang S, Maser RS, Mohan R, Artandi SE, Chin L, DePinho RA: Telomere dysfunction provokes regional amplification and deletion in cancer genomes. Cancer Cell. 2002, 2: 149-155. 10.1016/S1535-6108(02)00094-6.CrossRefPubMed
16.
go back to reference Aubele M, Cummings M, Walsch A, Zitzelsberger H, Nahrig J, Hofler H, Werner M: Heterogeneous chromosomal aberrations in intraductal breast lesions adjacent to invasive carcinoma. Anal Cell Pathology. 2000, 20: 17-24.CrossRef Aubele M, Cummings M, Walsch A, Zitzelsberger H, Nahrig J, Hofler H, Werner M: Heterogeneous chromosomal aberrations in intraductal breast lesions adjacent to invasive carcinoma. Anal Cell Pathology. 2000, 20: 17-24.CrossRef
17.
go back to reference Gong G, DeVries S, Chew KL, Cha I, Ljung BM, Waldman FM: Genetic changes in paired atypical and usual ductal hyperplasia of the breast by comparative genomic hybridization. Clin Cancer Res. 2001, 7: 2410-2414.PubMed Gong G, DeVries S, Chew KL, Cha I, Ljung BM, Waldman FM: Genetic changes in paired atypical and usual ductal hyperplasia of the breast by comparative genomic hybridization. Clin Cancer Res. 2001, 7: 2410-2414.PubMed
18.
go back to reference Buerger H, Otterbach F, Simon R, Poremba C, Diallo R, Decker T, Riethdorf L, Brinkschmidt C, Dockhorn-Dworniczak B, Boecker W: Comparative genomic hybridization of ductal carcinoma in situ of the breast-evidence of multiple genetic pathways. J Pathol. 1999, 187: 396-402. 10.1002/(SICI)1096-9896(199903)187:4<396::AID-PATH286>3.0.CO;2-L.CrossRefPubMed Buerger H, Otterbach F, Simon R, Poremba C, Diallo R, Decker T, Riethdorf L, Brinkschmidt C, Dockhorn-Dworniczak B, Boecker W: Comparative genomic hybridization of ductal carcinoma in situ of the breast-evidence of multiple genetic pathways. J Pathol. 1999, 187: 396-402. 10.1002/(SICI)1096-9896(199903)187:4<396::AID-PATH286>3.0.CO;2-L.CrossRefPubMed
19.
go back to reference Nishizaki T, DeVries S, Chew K, Goodson WH, Ljung BM, Thor A, Waldman FM: Genetic alterations in primary breast cancers and their metastases: direct comparison using modified comparative genomic hybridization. Genes Chromosomes Cancer. 1997, 19: 267-272. 10.1002/(SICI)1098-2264(199708)19:4<267::AID-GCC9>3.0.CO;2-V.CrossRefPubMed Nishizaki T, DeVries S, Chew K, Goodson WH, Ljung BM, Thor A, Waldman FM: Genetic alterations in primary breast cancers and their metastases: direct comparison using modified comparative genomic hybridization. Genes Chromosomes Cancer. 1997, 19: 267-272. 10.1002/(SICI)1098-2264(199708)19:4<267::AID-GCC9>3.0.CO;2-V.CrossRefPubMed
20.
go back to reference Odagiri E, Kanada N, Jibiki K, Demura R, Aikawa E, Demura H: Reduction of telomeric length and c-erbB-2 gene amplification in human breast cancer, fibroadenoma, and gynecomastia. Relationship to histologic grade and clinical parameters. Cancer. 1994, 73: 2978-2984.CrossRefPubMed Odagiri E, Kanada N, Jibiki K, Demura R, Aikawa E, Demura H: Reduction of telomeric length and c-erbB-2 gene amplification in human breast cancer, fibroadenoma, and gynecomastia. Relationship to histologic grade and clinical parameters. Cancer. 1994, 73: 2978-2984.CrossRefPubMed
21.
go back to reference Shay JW, Bacchetti S: A survey of telomerase activity in human cancer. Eur J Cancer. 1997, 33: 787-791. 10.1016/S0959-8049(97)00062-2.CrossRefPubMed Shay JW, Bacchetti S: A survey of telomerase activity in human cancer. Eur J Cancer. 1997, 33: 787-791. 10.1016/S0959-8049(97)00062-2.CrossRefPubMed
22.
go back to reference Morales CP, Holt SE, Ouellette M, Kaur KJ, Yan Y, Wilson KS, White MA, Wright WE, Shay JW: Absence of cancer-associated changes in human fibroblasts immortalized with telomerase. Nat Genet. 1999, 21: 115-118. 10.1038/5063.CrossRefPubMed Morales CP, Holt SE, Ouellette M, Kaur KJ, Yan Y, Wilson KS, White MA, Wright WE, Shay JW: Absence of cancer-associated changes in human fibroblasts immortalized with telomerase. Nat Genet. 1999, 21: 115-118. 10.1038/5063.CrossRefPubMed
23.
go back to reference Jiang XR, Jimenez G, Chang E, Frolkis M, Kusler B, Sage M, Beeche M, Bodnar AB, Wahl GM, Tlsty TD, Chiu CP: Telomerase expression in human somatic cells does not induce changes associated with a transformed phenotype. Nat Genet. 1999, 21: 111-114. 10.1038/5056.CrossRefPubMed Jiang XR, Jimenez G, Chang E, Frolkis M, Kusler B, Sage M, Beeche M, Bodnar AB, Wahl GM, Tlsty TD, Chiu CP: Telomerase expression in human somatic cells does not induce changes associated with a transformed phenotype. Nat Genet. 1999, 21: 111-114. 10.1038/5056.CrossRefPubMed
24.
go back to reference Stampfer MR, Garbe J, Levine G, Lichtsteiner S, Vasserot AP, Yaswen P: Expression of the telomerase catalytic subunit, hTERT, induces resistance to transforming growth factor beta growth inhibition in p16INK4A(-) human mammary epithelial cells. Proc Natl Acad Sci USA. 2001, 98: 4498-4503. 10.1073/pnas.071483998.CrossRefPubMedPubMedCentral Stampfer MR, Garbe J, Levine G, Lichtsteiner S, Vasserot AP, Yaswen P: Expression of the telomerase catalytic subunit, hTERT, induces resistance to transforming growth factor beta growth inhibition in p16INK4A(-) human mammary epithelial cells. Proc Natl Acad Sci USA. 2001, 98: 4498-4503. 10.1073/pnas.071483998.CrossRefPubMedPubMedCentral
25.
go back to reference Artandi SE, Alson S, Tietze MK, Sharpless N, Ye S, Greenberg R, Castrillion D, Horner J, Weiler S, Carrasco R, DePinho RA: Constitutive telomerase expression promotes mammary carcinomas in aging mice. Proc Natl Acad Sci USA. 2002, 99: 8191-8196. 10.1073/pnas.112515399.CrossRefPubMedPubMedCentral Artandi SE, Alson S, Tietze MK, Sharpless N, Ye S, Greenberg R, Castrillion D, Horner J, Weiler S, Carrasco R, DePinho RA: Constitutive telomerase expression promotes mammary carcinomas in aging mice. Proc Natl Acad Sci USA. 2002, 99: 8191-8196. 10.1073/pnas.112515399.CrossRefPubMedPubMedCentral
26.
go back to reference Gonzalez-Suarez E, Samper E, Ramirez A, Flores JM, Martin-Caballero J, Jorcano JL, Blasco MA: Increased epidermal tumors and increased skin wound healing in transgenic mice overexpressing the catalytic subunit of telomerase, mTERT, in basal keratinocytes. EMBO J. 2001, 20: 2619-2630. 10.1093/emboj/20.11.2619.CrossRefPubMedPubMedCentral Gonzalez-Suarez E, Samper E, Ramirez A, Flores JM, Martin-Caballero J, Jorcano JL, Blasco MA: Increased epidermal tumors and increased skin wound healing in transgenic mice overexpressing the catalytic subunit of telomerase, mTERT, in basal keratinocytes. EMBO J. 2001, 20: 2619-2630. 10.1093/emboj/20.11.2619.CrossRefPubMedPubMedCentral
Metadata
Title
Complex roles for telomeres and telomerase in breast carcinogenesis
Author
Steven E Artandi
Publication date
01-02-2002
Publisher
BioMed Central
Published in
Breast Cancer Research / Issue 1/2002
Electronic ISSN: 1465-542X
DOI
https://doi.org/10.1186/bcr553

Other articles of this Issue 1/2002

Breast Cancer Research 1/2002 Go to the issue
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine